About us since its establishment in the year 1987, sangrose has grown phenomenally in being one of the largest producers of anti leprotic api clofazimine in the world. Sangrose is one of the leading manufacturers of soft gelatin capsules in india. The foray of sangrose into the regulated market is through continuous development of facilities as per the latest standards. The motto of the company is to achieve excellence in bringing out therapeutically effective products Sangrose is today a globally recognized, pharmaceutical company with core competencies in development and manufacture of active pharmaceutical ingredients (apis) and finished dosage forms. From the very inception, sangrose has been investing aggressively for establishing modern research and manufacturing facilities aimed at global markets, thus emerging as a world-class pharmaceutical company with in house facility covering the entire value chain from production to marketing. Genesis Mr. c k alexander, an entrepreneur-research chemist, founded sangrose laboratories in the year 1987. The dna of the company is drawn from its founder and his vision to establish worlds only and largest producer of clofazimine. In fact, it is this spirit of entrepreneurship that has shaped the company to become what it is today. The vision of a research chemist takes on social and commercial expressions thats in a nutshell, briefly explains the genesis and growth of sangrose labs. Mr. ck alexander the founder and managing director was born and brought up in the traditions of kerala. After acquiring his m sc in chemistry he joined a pharmaceutical company and he started his career as a chemist. Sheer dint of hard work and determination enabled him to achieve the top management positions in various pharmaceutical majors. After acquiring more than 30 years of experience his attachment to his motherland brought him back to his own land to contribute towards keralas people and economy. His vast experience blended with entrepreneurial skill triggered him to start a company like this. He started production of clofazimine in the year 1989 with an initial capacity of one tonne/ annum. After that there was no looking back.

Company having Japanese health authority certified plant.

The company attained enhanced production capacity up to 18 tons per annum.